IL2 and rheumatoid arthritis: In addition, a prospective clinical study conducted in patients with mild to moderate forms of autoimmune disease, including RA, demonstrated the safety of an injection protocol consisting of a small amount of IL-2 (1 × 106 IU/day) for five days, followed by fortnightly injections for six months [82].